These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31149571)

  • 21. A comparison of family physician and dermatologist topical corticosteroid prescriptions: A population-based cross-sectional study.
    Bowie AC; Tadrous M; Thiruchelvam D; Ivers NM; Mohan T; Tu K; Jaakkimainen L; Drucker AM
    J Am Acad Dermatol; 2023 Jun; 88(6):1291-1299. PubMed ID: 36914480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Misuse of topical corticosteroids on facial skin. A study of 200 patients.
    Sharma R; Abrol S; Wani M
    J Dermatol Case Rep; 2017 Mar; 11(1):5-8. PubMed ID: 28539982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of nonprescription topical steroids: patients' experiences.
    Rogers PJ; Wood SM; Garrett EL; Krykant SP; Haddington NJ; Hayhurst J; Player GR
    Br J Dermatol; 2005 Jun; 152(6):1193-8. PubMed ID: 15948981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Misuse of Topical Corticosteroids over Face: A Clinical Study.
    Manchanda K; Mohanty S; Rohatgi PC
    Indian Dermatol Online J; 2017; 8(3):186-191. PubMed ID: 28584755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The reservoir effect of topical steroids in vitiliginous skin: A cross-sectional study.
    Singh SK; Nasir F
    Indian J Dermatol Venereol Leprol; 2015; 81(4):370-5. PubMed ID: 26144851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improper Use of Topical Corticosteroids in Tinea Infections in a Tertiary Care Hospital.
    Paudel S; Parajuli N; Dahal SC; Paudel S
    J Nepal Health Res Counc; 2021 Apr; 19(1):71-75. PubMed ID: 33934136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Qualitative analysis of topical corticosteroid concerns, topical steroid addiction and withdrawal in dermatological patients.
    Tan S; Phan P; Law JY; Choi E; Chandran NS
    BMJ Open; 2022 Mar; 12(3):e060867. PubMed ID: 35296492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Male genital dermatophytosis - clinical features and the effects of the misuse of topical steroids and steroid combinations - an alarming problem in India.
    Verma SB; Vasani R
    Mycoses; 2016 Oct; 59(10):606-14. PubMed ID: 27028087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study of Clinical Profile of Patients Presenting with Topical Steroid-Induced Facial Dermatosis to a Tertiary Care Hospital.
    Jain S; Mohapatra L; Mohanty P; Jena S; Behera B
    Indian Dermatol Online J; 2020; 11(2):208-211. PubMed ID: 32477980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The knowledge of issues associated with topical corticosteroids using in patients with atopic dermatitis.
    Jaworek A; Szafraniec K; Pastuszczak M; Zalewski A; Wojas-Pelc A
    Pol Merkur Lekarski; 2019 Jun; 46(276):243-247. PubMed ID: 31260432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relative efficacy and interchangeability ofvarious clobetasol propionate vehicles in the management of steroid-responsive dermatoses.
    Feldman SR
    Curr Ther Res Clin Exp; 2005 May; 66(3):154-71. PubMed ID: 24672120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pattern of topical corticosteroid prescribing in the United States, 1989-1991.
    Stern RS
    J Am Acad Dermatol; 1996 Aug; 35(2 Pt 1):183-6. PubMed ID: 8708016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topical Steroid Damaged/Dependent Face (TSDF): A Study from a Tertiary Care Hospital in Eastern India.
    Pal D; Biswas P; Das S; De A; Sharma N; Ansari A
    Indian J Dermatol; 2018; 63(5):375-379. PubMed ID: 30210157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dermatologists' knowledge of and preferences regarding topical steroids.
    Sandoval LF; Davis SA; Feldman SR
    J Drugs Dermatol; 2013 Jul; 12(7):786-9. PubMed ID: 23884491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Spectrum of Cutaneous Adverse Drug Reactions Following the Application of Topical Medications: An Observational Study at a Tertiary Care Center.
    Makwana VS; Bhadja SG; Songara BM; Patel ZR; Vyas AP
    Cureus; 2022 Aug; 14(8):e28139. PubMed ID: 36134045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medication Practice of Patients with Dermatophytosis.
    Poudyal Y; Joshi SD
    JNMA J Nepal Med Assoc; 2016; 55(203):7-10. PubMed ID: 27935915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective study on patterns of topical steroids self-use in dermatophytoses and determinants predictive of cutaneous side effects.
    Khurana A; Gupta A; Sardana K; Sethia K; Panesar S; Aggarwal A; Ghadlinge M
    Dermatol Ther; 2020 Jul; 33(4):e13633. PubMed ID: 32449316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical corticosteroid use for atopic dermatitis in the pediatric emergency department.
    Wang JF; Young TK; Melnick LE; Orlow SJ; Oza VS
    Pediatr Dermatol; 2021 Sep; 38(5):1127-1131. PubMed ID: 33870556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnitude, characteristics and consequences of topical steroid misuse in rural North India: an observational study among dermatology outpatients.
    Thomas M; Wong CC; Anderson P; Grills N
    BMJ Open; 2020 May; 10(5):e032829. PubMed ID: 32430446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Duration of topical therapy in the maintenance of atopic dermatitis remission in pediatric age.
    Pecoraro L; Florile M; Piazza M; Comberiati P; Clemente M; Tadiotto E; Pietrobelli A; Piacentini G
    Minerva Pediatr (Torino); 2021 Aug; 73(4):294-300. PubMed ID: 29968448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.